Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Radiation treatment can be delayed after prostatectomy to prevent side effects, say studies

Important news for men receiving treatment for prostate cancer: Two new studies from the University of Virginia School of Medicine have upended the widely held view that it's best to delay radiation treatment as long as possible after the removal of the prostate in order to prevent unwanted side effects.

23 Mar 2015

Study finds no added benefit from sipuleucel-T in men with metastatic prostate cancer

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or no symptoms and do not yet require chemotherapy. In the dossier assessment conducted by the German Institute for Quality and Efficiency in Health Care (IQWiG) in January 2015, no added benefit could be derived for sipuleucel-T.

22 Mar 2015

MED15 may serve as prognostic marker for HNSCC recurrence

A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study published in The American Journal of Pathology.

21 Mar 2015

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab.

19 Mar 2015

Researchers reveal how omega-3 fatty acids inhibit growth of prostate cancer cells

Washington State University researchers have found a mechanism by which omega-3 fatty acids inhibit the growth and spread of prostate cancer cells. The findings, which are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, point the way to more effective anti-cancer drugs.

18 Mar 2015

NCCN panelists discuss on evidence-based decision-making at bedside

On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care, the National Comprehensive Cancer Network hosted its second roundtable, Value-Based Decision-Making at the Bedside, which reflected on the tools available to oncology clinicians, such as clinical practice guidelines and pathways, and how the use of these tools has impacted bedside evidence-based decision-making for both physicians and patients, the criteria used to assess shared decision-making, and the relationship between outcomes and cost when determining value.

18 Mar 2015

Study may help men make better decisions about aggressive prostate cancer treatments

A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments.

17 Mar 2015

Study defines new subtype of 'lethal' prostate cancer

A University of Colorado Cancer Center study published in the journal Cancer Research defines a new, distinct subtype of "lethal" prostate cancer marked by the loss of two genes, MAP3K7 and CHD1. Overall about 10 percent of men with prostate cancer will die from the disease.

16 Mar 2015

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the commercial availability of NATESTO (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism.

16 Mar 2015

ERC project aims to identify new treatments for prostate cancer

The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab at the Institute for Research in Biomedicine (IRB Barcelona).

13 Mar 2015

AdMeTech Foundation announces launch of statewide prostate cancer awareness program

AdMeTech Foundation today announced the launch of a statewide prostate cancer education and awareness campaign supported by the Massachusetts Department of Public Health.

12 Mar 2015

Early mobility therapy improves outcomes of patients with acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition that affects approximately 200,000 people a year in the United States and has a higher mortality rate than breast and prostate cancer combined. The condition most often occurs in people who are critically ill or who have significant injuries; those who do survive it often experience profound skeletal muscle weakness.

12 Mar 2015

Researchers develop improved MRI technique to provide effective treatment for prostate cancer

A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.

10 Mar 2015

Depression symptoms under-recognized in African-American cancer patients

Case Western Reserve University nurse scientist Amy Zhang, who has long examined quality-of-life issues in cancer patients, wondered whether depression in African-American cancer patients has been under-recognized for treatment.

10 Mar 2015

Whole genome sequencing may help identify disease risks

Using a small amount of blood or saliva, a technology called whole genome sequencing makes that possible - and more than half of parents said they'd not only be interested in the technology for themselves but for their children too, a new nationally-representative University of Michigan study shows.

10 Mar 2015

Study: A family history of prostate cancer may increase women's risk of developing breast cancer

Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

10 Mar 2015

Severe mortality-associated diseases less prevalent in members of long-lived families

Recent research from the Long Life Family Study (LLFS) confirms that severe mortality-associated diseases are less prevalent in the families of long-lived individuals than in the general population. The Journals of Gerontology, Series A will publish these findings in the article titled, "Are Members of Long-Lived Families Healthier than Their Equally Long-Lived Peers? Evidence from the Long Life Family Study" on March 5, 2015.

6 Mar 2015

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

Novogen today announces that Professor Gil Mor MD PhD from Yale Medical School will be presenting pre-clinical data on the lead candidate product, Cantrixil, at two upcoming conferences.

6 Mar 2015

Blue Cross Blue Shield of Michigan, UMHS announce new initiative to enhance genetic testing practices

Blue Cross Blue Shield of Michigan and the University of Michigan Health System are collaborating with physicians and laboratories across the state as part of a new initiative to improve genetic testing practices.

5 Mar 2015

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot study to assess the feasibility of VolitionRx's proprietary NuQ assays in detecting prostate cancer.

5 Mar 2015

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Radiation treatment can be delayed after prostatectomy to prevent side effects, say studies

Study finds no added benefit from sipuleucel-T in men with metastatic prostate cancer

MED15 may serve as prognostic marker for HNSCC recurrence

Janssen announces acquisition of XO1

Researchers reveal how omega-3 fatty acids inhibit growth of prostate cancer cells

NCCN panelists discuss on evidence-based decision-making at bedside

Study may help men make better decisions about aggressive prostate cancer treatments

Study defines new subtype of 'lethal' prostate cancer

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

ERC project aims to identify new treatments for prostate cancer

AdMeTech Foundation announces launch of statewide prostate cancer awareness program

Early mobility therapy improves outcomes of patients with acute respiratory distress syndrome

Researchers develop improved MRI technique to provide effective treatment for prostate cancer

Depression symptoms under-recognized in African-American cancer patients

Whole genome sequencing may help identify disease risks

Study: A family history of prostate cancer may increase women's risk of developing breast cancer

Severe mortality-associated diseases less prevalent in members of long-lived families

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

Blue Cross Blue Shield of Michigan, UMHS announce new initiative to enhance genetic testing practices

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

What to know about prostate cancer eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in